Arrowhead Pharmaceuticals (ARWR) Interest & Investment Income (2022 - 2026)
Arrowhead Pharmaceuticals' Interest & Investment Income was $16.94 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 53.7% from $11.02 million a year earlier and up 0.4% from the prior quarter.
Arrowhead Pharmaceuticals (ARWR) Interest & Investment Income (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arrowhead Pharmaceuticals' Interest & Investment Income was $52.57 million through Jun 30, 2026, up 48.5% year-over-year; for FY2025 (ended Sep 30, 2025), it was $37.3 million, up 64.2% from FY2024.
- Interest & Investment Income has now increased for three consecutive fiscal years, with a four-year compound annual growth rate of 57.1% (FY2021 to FY2025).
- In earlier fiscal years, Interest & Investment Income was $22.72 million in FY2024 (+48.5%), $15.3 million in FY2023 (+204.0%), $5.03 million in FY2022 (-17.8%) and $6.12 million in FY2021.
- The fiscal Q3 2026 figure marks the highest quarterly Interest & Investment Income in data going back to fiscal Q2 2022.
- Compared with a year earlier, Interest & Investment Income has increased for 14 straight quarters, with growth averaging 70.3% over the last eight quarters.
- Over the past five years, the year-over-year growth in Interest & Investment Income ranged from 4.5% (fiscal Q1 2024) to 332.6% (fiscal Q2 2023).
- Per Business Quant data, ARWR's Interest & Investment Income in the three fiscal quarters before Q3 2026 was $16.87 million (Q2 2026), $9.7 million (Q1 2026) and $9.06 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 9.06 Bn | 3.84 Bn | - | 16.94 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.94 Mn |
| Mar 31, 2026 | 16.87 Mn |
| Dec 31, 2025 | 9.70 Mn |
| Sep 30, 2025 | 9.06 Mn |
| Jun 30, 2025 | 11.02 Mn |
| Mar 31, 2025 | 9.62 Mn |
| Dec 31, 2024 | 7.60 Mn |
| Sep 30, 2024 | 7.17 Mn |
| Jun 30, 2024 | 6.50 Mn |
| Mar 31, 2024 | 6.25 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Sep 30, 2023 | 3.89 Mn |
| Jun 30, 2023 | 4.17 Mn |
| Mar 31, 2023 | 4.56 Mn |
| Dec 31, 2022 | 2.68 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 1.24 Mn |
| Mar 31, 2022 | 1.05 Mn |
Arrowhead Pharmaceuticals Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();